Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: J Allergy Clin Immunol. 2014 Apr 29;133(6):1626–1634. doi: 10.1016/j.jaci.2014.03.003

Figure 3.

Figure 3

Significant down-regulation of inflammatory markers following CsA in AD skin as quantified by real-time/RT-PCR. A–X) Post-versus-pre-treatment mRNA expression differences (FCHs) of selected genes, as grouped by the inflammatory pathway, in LS and NL AD at wks2 and 12 of treatment. Wk/week; FCH/fold-change; Mean±SEM with post-versus-pre p-values. See Table E3 in OR for confidence intervals.

HHS Vulnerability Disclosure